- Thoracic (Lung) Cancer Program / TeamBillings Clinic Cancer Center
- To Make an Appointment:
801 North 29th St
Billings, MT 59101
The lung cancer program is led by team leader Brendan Bellew, MD, PhD, and patient care navigator Cindy Frank, RN, OCN. Other team members include highly skilled surgeons, pulmonologists, medical oncologists, and radiation oncologists.
Lung CT screening is available at Billings Clinic for the early detection of lung cancer in high-risk patients. Click here to view our Lung CT Screening brochure.
The lung cancer multidisciplinary team at Billings Clinic has diagnosed a higher percentage of early stage lung cancer than other similar programs. The team provides state-of-the-art diagnostics, appropriate and timely follow-up, and research support. In addition, our lung malignancy specialists are available for consult, including second opinions of previously diagnosed cancers and treatment options through our Multidisciplinary Lung Center.
The Billings Clinic Multidisciplinary Lung Center is a coordinated multi-specialty clinic for patients with diagnosed or suspected lung cancer.
How does it work?
- Patients are referred to the center by a Billings Clinic medical provider, an outside medical provider, or themselves.
- A patient care navigator contacts the patient and coordinates appointments for diagnostic lab, imaging and medical consults per physician order.
- The patient meets with the patient care navigator who accompanies them to provider appointments.
- A preliminary plan is completed and the case is referred to the next scheduled Lung Conference/Tumor Board.
- Final findings and treatment recommendations are presented to the patient by the lead provider.
- The patient care navigator coordinates follow up appointments for treatment.
What are the advantages?
- Enhanced referral experience for the patient
- Fostered physician collaboration during treatment planning
- Expeditious medical management
- Patient provided with clear understandable information regarding their diagnosis, treatment, and possible outcomes
Our clinical trials program is investigating the latest chemotherapeutic and targeted therapy for early- and late-stage lung cancer. .
Treatment options for lung cancers often involve multiple treatment modalities. Members of the multidisciplinary team participate in a Lung Tumor Board every two weeks to review cases and ensure best treatment practices are offered to patients.